Allergy

Article	Citations
In this Issue: Graphical Abstracts	735
Issue Information	359
Issue Information	321
Issue Information	276
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	228
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	178
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	170
Type 2 memory B cells: The repository of allergic memory?	161
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	156
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	151
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	149
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	145
Immunoglobulin E response in health and disease beyond allergic disorders	130
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	113
	112
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	107
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	107
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	105
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	104
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	96
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	96
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	95
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	93
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	88
In memoriam: Lawrence M. Lichtenstein (1934–2022)	88

MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	84
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	83
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	80
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	79
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	77
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	76
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	75
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	72
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	71
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	70
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	69
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	67
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	67
Development and validation of the food allergy severity score	67
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	66
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	66
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP and Radioallergosorbent Test	65
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	64
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	63
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs	63
Issue Information ‐ TOC	63
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	63
In this Issue: Graphical Abstracts	62
Issue Information	61
Issue Information	59
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis	58
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders	58
Mast cell activation is associated with post‐acute COVID‐19 syndrome	57
Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD	56
Severe and refractory anaphylaxis in pediatric intensive care unit	55
	55
Type 2 IgG Memory B Cells as Precursors of IgE Plasma Cells	55
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	53
Oral abstracts (OAS)	52
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	51
Recurrence of anaphylaxis: A systematic review of observational studies	51
Issue Information	51
The Molecular Allergology User's Guide version 2.0 is freely available!	51
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation	50
Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants	50
Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation	50
Management of anaphylaxis due to COVID‐19 vaccines in the elderly	50
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”	49
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice	49
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades	49
Non‐immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross‐reactivity with other iodinated contrast media	49
Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications	49
EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics	48
NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge	48
Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages	47

Anatomical Distribution and Quantification of IgE Secretion in Mouse Models of House Dust Mite Allergy	47
Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up	47
Gastrointestinal Barrier Disruption in Post‐COVID Syndrome Fatigue Patients	46
Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging	45
Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1	45
Discrepancies in Beta‐Lactam Antibiotics Cross‐Reactivity: Implications for Clinical Practice	45
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy	44
CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study	44
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild‐to‐moderate atopic dermatitis: A randomized, double‐blind, vehicle‐controlled trial	43
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization	42
TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma	42
Neuron−macrophage interaction in the healing process of the skin	42
Issue Information	41
In this issue: Graphical abstract	41
Impact of a drug allergy education course for non‐specialists: Findings from ADAPT—A randomized crossover trial	41
Issue Information	40
IL‐13: An essential cDC2s partner to maintain skin homeostasis	40
Harnessing mass spectrometric methods for exquisite allergen product characterization	40
Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG, Promotes Th1 Responses and Reduces Anaphylactic Potential	40
Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy	39
SEB‐induced IL‐13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis	39
Abstract	39
Optimal dose of adrenaline auto‐injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study	38
A vaccine targeting human IL‐4 and IL‐13 protects against asthma in humanized mice	38
SARS‐CoV‐2 infection in severe asthma is associated with worsening of COVID‐19 through respiratory NLRP3 inflammasome activation	38
Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control—A Systematic Review for the EAACI Guidelines of Environmental Science for Al	38
COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy	37
Food Allergy Genetics and Epigenetics: A Review of Genome‐Wide Association Studies	37
Emollients for prevention of atopic dermatitis: 5‐year findings from the BEEP randomized trial	36
Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID‐19 pandemic	36
Indirect case‐matched comparison of anti‐IL4Rα versus anti‐IL5Rα on airway hyperresponsiveness	36
Oncostatin‐M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma	36
Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms	36
Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study	36
Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions	35
Effect of venom immunotherapy and sting challenge on health‐related quality of life measured by venom‐allergy quality of life questionnaire (VQLQ) in Jack jumper ant allergic patients	35
Legends of allergy and immunology: Otto Scheiner	35
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma	34
Salivary Metabolomic Signatures in Pediatric Eosinophilic Esophagitis	34
Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life	34
Development of the Cold Urticaria Activity Score	34
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry	34
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy	34
Quantitative analysis of urinary cytokines in food‐allergic and healthy individuals	34
Exiting the Anthropocene: Achieving personal and planetary health in the 21st century	34
Cashew oral immunotherapy for desensitizing cashew‐pistachio allergy (NUT CRACKER study)	34
Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria	33
Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins	33
Vulnerability to Pollen‐Related Asthma Hospital Admissions in the UK Biobank: A Case‐Crossover Study	33
	32
Efficacy and Safety Profile of Animal Dander Immunotherapy: A Multicentre UK Study	32
Efficacy of eHealth monitoring in pediatric asthma	32
Addressing the Growing Role of Junior Members in EAACI	32
Issue Information	32
	32
Sex hormones and asthma: The role of estrogen in asthma development and severity	32
Issue Information	32
Author Index	32
IgE glycosylation is essential for the function of omalizumab	31
Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?	31
IL‐13, periostin and dipeptidyl‐peptidase‐4 reveal endotype‐phenotype associations in atopic dermatitis	31
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination	31
Particulate Matter 2.5 Aggravates Airway Inflammation by Neutrophil‐Mediated Inflammasome Activation	30
Safety of COVID‐19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi‐centre cohort study	30
Can polyamine metabolism in T helper cell lineage commitment be a new target in allergy research?	30
Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation	30
Is there a direct link between skin barrier dysfunction and asthma?	30
Interferon‐γ‐inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response	30
Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction	30
Gut microbiota and Lactobacillus species maintain the small intestine stem cell niche and ameliorate the severity of necrotizing enterocolitis	30
CLA+ memory T cells in atopic dermatitis	30
The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients	30
Legends of Allergy and Immunology: Gianni Marone	30
On a Rainy Day, Placebo Is the Ideal Treatment for Your Hay Fever	29
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy	29
Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation	29
Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial	29
Long‐term follow‐up of neutrophil activation after severe‐to‐critical SARS‐CoV‐2 infection: A longitudinal study	29
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis	29
Climate change: A call to action for the United Nations	28

The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor	28
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production	28
Epidemiological variations in global burden of atopic dermatitis: An analysis of trends from 1990 to 2019	28
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper	28
Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper	27
Differentiation of bronchial epithelial spheroids in the presence of IL‐13 recapitulates characteristic features of asthmatic airway epithelia	27
Recombinant Hypoallergenic Cat Allergy Vaccines	27
Advances and highlights in asthma in 2021	27
Pre‐Analytical Stability of Diagnostic Biomarkers in Primary Blood Tubes for Supporting Remote Allergy Care	27
Basal Serum Tryptase Outperforms Hereditary Alpha Tryptasemia as a Biomarker of Food Allergy Severity	27
Different mechanisms distinguishing childhood allergic diseases including allergic march	27
Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps	27
Poultry exposure and environmental protection against asthma in rural children	27
In this issue: Graphical abstract	26
Issue Information	26
Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease	26
Effect‐modifying impact of age on sex‐based differences during oral immunotherapy	26
Infantile colic is associated with development of later constipation and atopic disorders	26
Neonatal BCG Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial	26
Author Index	26
Issue Information	26
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies	25
Correction to “Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge”	25
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis	25
Obituary: Professor Marcus Maurer, Berlin, Germany	25
An algorithm for the management of radiocontrast media hypersensitivity, 2024 update	24
Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps	24
Systematic review of the association between short‐chain fatty acids and allergic diseases	24
Human Milk Microbiome Is Associated With Allergic Diseases in Early Childhood	24
Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years	24
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas	24
How type‐2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell‐T cell communication?	24
Corrigendum to “Immune Regulation by Intralymphatic Immunotherapy With Modular Allergen Translocation MAT Vaccine”	24
COVID‐19 pandemic and allergen immunotherapy—an EAACI survey	23
Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?	23
The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID‐19): A national survey in China	23
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study	23
Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis	23
Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps	23
Allergenic potency of various foods of mammalian origin in patients with α‐Gal syndrome	23
Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database	23
Long‐term changes in milk component immunoglobulins reflect milk oral immunotherapy outcomes in Finnish children	23
Dietary fiber and fermented food consumption and its link to allergic responses	23
Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma	23
Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL‐2, IL‐3, IL	23
Sesame eliciting and safe doses in a large sesame allergic population	23
Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire	23
Effect of indoor air pollution on atopic dermatitis in dogs	23
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta‐analysis	23
Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases	23
TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis‐like transcriptomes	22
Reply to Correspondence: ‘Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management’	22
Anaphylaxis Induced by Goat's and Sheep's Milk: An Allergen That We Should Keep Under Surveillance	22
Helminths' therapeutic potential to treat intestinal barrier dysfunction	22
Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis	22
Different inflammatory features of asthma according to gut microbiome enterotype	22
Inverse association between Helicobacter pylori infection and atopic, skin, and autoimmune diseases: A nationwide population‐based study in South Korea	22
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study	22
Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition	21
Corrigendum: Role of yes‐associated protein in interleukin‐13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps	21
Issue information ‐ Cover and Editorial Board	21
Issue Information ‐ TOC	21
Algorithm for the Management of Primary Diffuse Chronic Rhinosinusitis	21
	21
Issue Information	21
Tetraspanin CD53 Promotes Inflammation but Restrains Mucus Production in a Mouse Model of Allergic Airway Inflammation	21
Vitamin D‐FUT2 interaction and risk of lower respiratory tract infections in childhood	21
Issue Information ‐ TOC	21
Dupilumab and Blood Eosinophilia: A Disease‐Specific Phenomenon?	21
Issue Information	21
Graphical abstracts and highlights	21
Legends of allergy and immunology: Alberto Mantovani, a visionary scientist unraveling the complexity of innate immunity in cancer and inflammation	21
Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma	21
Lupin, a potential “hidden” food anaphylaxis allergen: An alert from the Allergy‐Vigilance Network®	20
Migration and allergic diseases: Findings from a population‐based study in adults in Amsterdam, the Netherlands	20
Up‐dosing of reslizumab in severe asthmatics with persistent sputum eosinophilia: A feasibility study	20
	20
Induction of immunosuppressive CD39 but not the trafficking C‐C chemokine receptor 4 on Treg during LAR in mite allergic asthma	20
Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens	20
Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection	20
Immune‐epithelial barrier interactions mediate intestinal adaptation to diverse diets	19
Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction	19
On the role of antibody affinity and avidity in the IgE‐mediated allergic response	19
Human nasal epithelial cells express IL‐5Rα but not the co‐receptor CSF2RB and do not signal to IL‐5	19
Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response and asthma control in preschool children with asthma	19
CMTM4 as a new partner for IL‐17 receptor: Adding a piece in the puzzle of IL17‐driven diseases	19
Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling	19
An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype	19
Anaphylaxis and desensitization differently activate and induce IL‐8 release by mast cells in a human peanut allergy in vitro model	19
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances	19
Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations	19
Asthma endotypes in elite athletes: A cross‐sectional study of European athletes participating in the Olympic Games	19
The developing immune system in preterm born infants: From contributor to potential solution for respiratory tract infections and wheezing	19
Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation	19
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration	19